The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations
Experts find that in a healthy population, H. pylori eradication limits gastric cancer.
The Parent Has a Cancer Gene—Should the Child Get Surgery?
An article in the Wall Street Journal reviews a very rare mutation that can cause gastric cancer (subscription required). Want to learn more... Read More
Imugene’s shares surge higher following early promise in gastric cancer trial
Check out Imugene’s latest clinical results, with early but promising results of an immunotherapy treatment for gastric cancer.
New GI Cancer Studies: Curious Failures, Hidden Gems
Tune in for a review of the latest gastric cancer research Curious Failers, Hidden Gems, including more data From NORDIC-VII, Trastuzumab Emtansine,... Read More
Similarities found in cancer initiation in kidney, liver, stomach, pancreas
Researchers at Washington University School of Medicine in St. Louis show how mature cells begin dividing rapidly when responding to injury, creating... Read More
The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites
What’s changing in gastric cancer? Noncardia stomach cancer cases are increasing for people who under 50 years-old.
Staging and surgical approaches in gastric cancer: A systematic review
Researchers from Oncology Advance take a holistic look at staging and surgical approaches for gastric cancer.
Unmet needs and challenges in gastric cancer: The way forward
Check out this forward-looking article about new approaches to treating gastric cancer.
A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer
A study in the European Journal of Cancer shows nab-paclitaxel with ramucirumab may benefit patients with previously treated advanced gastric cancer.
FDA approves new treatment for certain digestive tract cancers
The U.S. Food and Drug Administration has approved the first radioactive drug (radiopharmaceutical) Lutathera for the treatment of gastroenteropancreatic neuroendocrine tumors.
